Kornitzer Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.01M | Buy |
99,560
+2,000
| +2% | +$168K | 0.19% | 111 |
|
|
2026
Q1 | $7.81M | Hold |
97,560
| – | – | 0.17% | 124 |
|
|
2025
Q4 | $8.32M | Sell |
97,560
-22,000
| -18% | -$1.81M | 0.17% | 127 |
|
|
2025
Q3 | $9.3M | Buy |
119,560
+25
| +0% | +$1.95K | 0.19% | 126 |
|
|
2025
Q2 | $9.35M | Hold |
119,535
| – | – | 0.19% | 142 |
|
|
2025
Q1 | $8.66M | Hold |
119,535
| – | – | 0.18% | 148 |
|
|
2024
Q4 | $8.85M | Hold |
119,535
| – | – | 0.17% | 172 |
|
|
2024
Q3 | $7.89M | Buy |
119,535
+27,985
| +31% | +$2.03M | 0.15% | 205 |
|
|
2024
Q2 | $8.46M | Buy |
91,550
+50
| +0.1% | +$4.43K | 0.16% | 186 |
|
|
2024
Q1 | $8.74M | Sell |
91,500
-57,501
| -39% | -$4.83M | 0.16% | 190 |
|
|
2023
Q4 | $11.4M | Buy |
149,001
+22,950
| +18% | +$1.6M | 0.22% | 143 |
|
|
2023
Q3 | $8.73M | Hold |
126,051
| – | – | 0.18% | 183 |
|
|
2023
Q2 | $11.9M | Sell |
126,051
-20,000
| -14% | -$1.74M | 0.23% | 137 |
|
|
2023
Q1 | $12.1M | Sell |
146,051
-5,725
| -4% | -$450K | 0.24% | 132 |
|
|
2022
Q4 | $11.3M | Buy |
151,776
+9,550
| +7% | +$736K | 0.23% | 134 |
|
|
2022
Q3 | $11.8M | Sell |
142,226
-15,841
| -10% | -$1.52M | 0.25% | 125 |
|
|
2022
Q2 | $15M | Sell |
158,067
-32,641
| -17% | -$3.38M | 0.3% | 98 |
|
|
2022
Q1 | $22.4M | Buy |
190,708
+157,987
| +483% | +$17.7M | 0.37% | 80 |
|
|
2021
Q4 | $4.24M | Buy |
32,721
+11,075
| +51% | +$1.29M | 0.06% | 292 |
|
|
2021
Q3 | $2.45M | Sell |
21,646
-3,551
| -14% | -$405K | 0.04% | 346 |
|
|
2021
Q2 | $2.61M | Hold |
25,197
| – | – | 0.04% | 340 |
|
|
2021
Q1 | $2.11M | Hold |
25,197
| – | – | 0.03% | 354 |
|
|
2020
Q4 | $2.3M | Hold |
25,197
| – | – | 0.04% | 336 |
|
|
2020
Q3 | $2.01M | Sell |
25,197
-614
| -2% | -$47.9K | 0.04% | 321 |
|
|
2020
Q2 | $1.78M | Sell |
25,811
-240,511
| -90% | -$17.1M | 0.04% | 337 |
|
|
2020
Q1 | $16.7M | Buy |
+266,322
| New | +$19.2M | 0.4% | 82 |
|
|
2018
Q1 | – | Sell |
-13,980
| Closed | -$525K | – | 474 |
|
|
2017
Q4 | $525K | Sell |
13,980
-66,150
| -83% | -$2.43M | 0.01% | 429 |
|
|
2017
Q3 | $2.92M | Sell |
80,130
-30,180
| -27% | -$1.15M | 0.05% | 285 |
|
|
2017
Q2 | $4.35M | Buy |
+110,310
| New | +$4.03M | 0.08% | 274 |
|
|
2016
Q1 | – | Sell |
-409,590
| Closed | -$10.8M | – | 459 |
|
|
2015
Q4 | $10.8M | Sell |
409,590
-110,400
| -21% | -$2.87M | 0.18% | 189 |
|
|
2015
Q3 | $12.3M | Buy |
519,990
+28,050
| +6% | +$677K | 0.2% | 169 |
|
|
2015
Q2 | $11.7M | Buy |
491,940
+111,540
| +29% | +$2.52M | 0.16% | 182 |
|
|
2015
Q1 | $9.03M | Buy |
+380,400
| New | +$8.53M | 0.11% | 213 |
|
Other funds holding EW
WT
BHIA
NONA
SIM
Kornitzer Capital Management's EW Position: Q2 2026 in Review
Kornitzer Capital Management increased its Edwards Lifesciences (EW) stake by 2.1% in Q2 2026, buying an estimated $168K and bringing the position to 99,560 shares worth $9.01M. The position accounts for 0.19% of the portfolio, ranked #111.
Kornitzer Capital Management first reported a position in EW in Q1 2015 and has held it in 33 quarters since. The position peaked at $22.4M in Q1 2022. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Kornitzer Capital Management held 99,560 shares of Edwards Lifesciences worth $9.01M as of Q2 2026.
- Kornitzer Capital Management bought 2,000 Edwards Lifesciences shares in Q2 2026, an estimated $168K.
- Edwards Lifesciences made up 0.19% of Kornitzer Capital Management's portfolio in Q2 2026, its #111 holding.
- Kornitzer Capital Management first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 33 quarters since.
- Kornitzer Capital Management's Edwards Lifesciences position peaked at $22.4M in Q1 2022.
- 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.